An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits

This publication has 28 references indexed in Scilit:

• Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan
  Vaccine, 2004
• Poly(γ-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule ofBacillus anthracis: A potential addition to the anthrax vaccine
  Proceedings of the National Academy of Sciences, 2003
• Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States
  Emerging Infectious Diseases, 2001
• Chitosan as a novel nasal delivery system for vaccines
  Advanced Drug Delivery Reviews, 2001
• Protection against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor Protein
  Infection and Immunity, 2001
• Clinical aspects, diagnosis and treatment of anthrax
  Journal of Applied Microbiology, 1999
• The effectiveness and safety of vaccines against human anthrax: a systematic review
  Vaccine, 1998
• Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system
  Immunologic Research, 1997
• Postexposure Prophylaxis against Experimental Inhalation Anthrax
  The Journal of Infectious Diseases, 1993
• Anthrax: the disease in relation to vaccines
  Vaccine, 1984